Global cerebral hypoxia following cardio-respiratory collapse due to anaphylaxis following administration of flucloxacillin in a man with diabetes mellitus, widespread sepsis and ischaemic heart disease
AI-generated summary
A 45-year-old man with poorly controlled diabetes, ischaemic heart disease, and recurrent lower limb infections died from anaphylaxis to intravenously administered flucloxacillin. He presented with sepsis secondary to a Staphylococcus aureus foot infection with bacteraemia. Blood cultures confirmed life-threatening infection on day 2-3 of admission. After 72 hours of meropenem without clinical improvement and overnight fever spikes, the treating physician (Dr C.) ordered flucloxacillin without re-consulting the infectious diseases specialist (Dr S.) who had previously only suggested it as a 'possible future treatment' pending further investigation. The drug was given in a general ward without cardiac monitoring. Immediate anaphylaxis ensued with cardiopulmonary arrest. The coroner found the death possibly preventable had Dr C. either chosen an alternative antibiotic or proceeded with flucloxacillin only with specialist input regarding appropriate dosing, penicillin challenge protocol, and a monitored critical care setting. Key clinical lessons: documented drug allergies require careful verification and communication; antibiotic stewardship decisions in complex sepsis cases need specialist re-consultation before implementation; anaphylaxis management requires immediate IM adrenaline and appropriate monitoring environment.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
general medicineinfectious diseasesemergency medicineintensive careallergy and immunology
Poorly documented and vague history of antibiotic allergies
Inadequate clarification of nature and severity of past allergic reactions
Absence of specialist re-consultation before administering flucloxacillin
Inappropriate setting for antibiotic administration (general ward without cardiac monitoring)
Failure to implement penicillin challenge protocol
Use of intravenous rather than intramuscular adrenaline
Initial hydrocortisone administration instead of immediate adrenaline
MET call rather than Code Blue activation
Pre-existing ischaemic heart disease increasing vulnerability to anaphylaxis complications
Complex co-morbidities including poorly controlled diabetes and renal impairment
Coroner's recommendations
Implement readily accessible and accurate electronic records of patients' past adverse reactions to antibiotics and other medications, with prominent alert mechanisms
Develop standardised adverse drug reaction (ADR) nomenclature for use across all Australian hospitals
Enhance documentation standards to clearly record the nature, severity and timing of allergic reactions
Provide clinical education to all staff about beta-lactam hypersensitivity, penicillin-containing agents and cross-reactivity between penicillins and cephalosporins
Develop and implement anaphylaxis protocols specifying recognition, classification and treatment standards
Reinforce that intramuscular adrenaline (not intravenous) is the first-line treatment for anaphylaxis
When penicillin antibiotics are considered despite documented allergy, administer in a critical care environment with full resuscitation facilities, close cardiac monitoring and staff trained in anaphylaxis management
Implement penicillin challenge protocols when clinically indicated
Ensure Code Blue (not MET call) is initiated for potential antimicrobial adverse drug reactions with hypotension or breathing difficulties
Require specialist re-consultation before implementing antibiotic recommendations, not just initial consultation
Update hospital policies on allergy documentation and management, particularly for antibiotic desensitisation scenarios
Improve communication and documentation of clinical decision-making rationale in cases involving medication allergies
Implement medication alert cards and coloured wristbands for patients with documented allergies or adverse reactions
Educate patients about clinical risks of inaccurate allergy reporting
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.